Search clinical trials for: LHRH agonist

Total 13719 results

Alliance Foundation Trials, LLC.
Janssen Research & Development, LLC

Active, not recruiting

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Prostate Cancer

United States
University of California, San Diego

Recruiting

ADRB3 Signaling Pathway in Human Adipose Tissue

Obesity, Prediabetes

United States
Ain Shams University

Recruiting

Evaluating the Outcome of Cardio Selective beta1- Blockers Use in Patients With Copd

Copd

Egypt
National Taiwan University Hospital

Completed

Predictors for Retreatement of OAB After DC Mirabegron

Recurrence of Overactive Bladder Syndrome

Taiwan
Astellas Pharma Inc

Completed

Long-Term Specified Drug Use-results Survey of Betanis Tablets

Overactive Bladder

Japan
Rochester Center for Behavioral Medicine
Shire

Completed

Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65). (ADINT2012)

Adult Attention-Deficit Hyperactivity Disorder

United States
Turku University Hospital

Recruiting

Prostate Medication, Metabolism and Gut Microbiota (PROMED)

Prostatic Hyperplasia | Prostate Cancer

Finland
Astellas Pharma Global Development, Inc.

Recruiting

A Study of Mirabegron in Young Children With Neurogenic Detrusor Overactivity

Neurogenic Detrusor Overactivity

Philippines, Turkey, Belgium, Denmark
Tianjin Medical University General Hospital

Recruiting

Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage

Intracerebral Haemorrhage

China
Paul Kim

Recruiting

Allograft Dysfunction in Heart Transplant

Heart Transplant Failure and Rejection

United States
Denver Health and Hospital Authority

Completed

Pupil Dilation for Treatment of IFIS

Intraoperative Floppy Iris Syndrome

United States
Timothy M. Bateman
Saint Luke's Health System; Saint Luke's Cardiovascular Consultants

Completed

Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging

Coronary Artery Disease

United States
Washington University School of Medicine
Astellas Pharma US, Inc.

Completed

Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (PET/MR-P)

Ischemic Heart Disease

United States
Icahn School of Medicine at Mount Sinai
Brain & Behavior Research Foundation

Completed

CRT-Guanfacine for SPD

Schizotypal Personality Disorder | SPD

United States
Emory University

Withdrawn

Phase Analysis and Obstructive CAD on Rubidium PET

Coronary Artery Disease

United States
Nanduri, Padma, M.D., FACS

Unknown

Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy

Glaucoma

United States
Mylan Bertek Pharmaceuticals

Completed

A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients

Hypertension

United States
Giulio Stefanini
Agenzia Italiana del Farmaco

Active, not recruiting

Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines (CONTROL)

Lymphoma, Large B-Cell, Diffuse | Breast Cancer | Chemotherapy Effect | Cardiotoxicity | Left Ventricular Dysfunction

Italy
Galderma R&D

Completed

Mirvaso in Use Study

Rosacea

United States
Shire

Completed

SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

ADHD

United States
Shire

Completed

Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17

Attention Deficit Disorder With Hyperactivity
Massachusetts Eye and Ear Infirmary

Completed

Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma

Glaucoma

United States
Neurology Group of Bergen County, P.A.
Shire

Completed

Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine

Attention-deficit/Hyperactivity Disorder

United States
Forest Laboratories

Completed

Nebivolol in Patients With Systolic Stage 2 Hypertension (NEB-MD-20)

Hypertension

United States
University of Parma

Completed

Brimonidine vs ALTP in Progressing Human Glaucoma

Glaucoma

Italy
University of Pittsburgh

Completed

Dexmedetomidine and Adenosine: Therapeutic Use for SVT

Supraventricular Tachycardia

United States
Rachel G. Greenberg, MD, MB, MHS
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Not yet recruiting

Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS) (HYP01)

Hyperactivity in Children With Down Syndrome | Impulsivity in Children With Down Syndrome

United States
Astellas Pharma Europe B.V.

Completed

Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity (Crocodile)

Neurogenic Detrusor Overactivity

Belgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
NYU Langone Health
Winthrop University Hospital

Withdrawn

Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Minneapolis Heart Institute Foundation
Forest Laboratories

Terminated

Alternative in Beta Blocker Intolerance: The ABBI Trial (ABBI)

Coronary Artery Disease

United States
Velicept Therapeutics, Inc.

Completed

Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Healthy Male Subjects

Healthy Subjects, Overactive Bladder
Astellas Pharma Inc

Completed

To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females

Healthy Subjects | Pharmacokinetics

Netherlands
St. Luke's-Roosevelt Hospital Center
GlaxoSmithKline

Terminated

Effect of a CCK-1R Agonist on Food Intake in Humans (GSK)

Bulimia

United States
University of Maryland, Baltimore
Astellas Pharma US, Inc.

Completed

Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing (Rega Stress)

Cardiac Function

United States
University of Chicago
Astellas Pharma Inc

Completed

Stress CT Perfusion in Patients With Chest Pain

Coronary Artery Disease

United States
The Hospital for Sick Children
Galderma R&D

Terminated

Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations

Capillary Malformations

Canada
Seoul National University Hospital

Unknown

Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease

Overactive Bladder | Parkinson Disease

Korea, Republic of
Augenarztpraxis Breisach

Unknown

Effect of Brimonidine on Corneal Thickness

Impact of Brimonidine on the Cornea

Germany
AstraZeneca

Completed

Assess Safety, Tolerability and PK of AZD3199 in Japanese

Healthy

United Kingdom
Maimonides Medical Center

Recruiting

Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome (PWS-GXR)

Aggression | Behavioral Symptoms | Pathologic Processes | Nervous System Diseases | Obesity | Neurologic Manifestations | Neurobehavioral Manifestations | Congenital Abnormalities | Overnutrition | Nutrition Disorders | Genetic Diseases, Inborn | Intellectual Disability | Self-Injurious Behavior | Abnormalities, Multiple and other conditions

United States
GE Healthcare
Covance

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients (Rapiscan PIP)

Myocardial Ischemia | Coronary Artery Disease

France, Greece, Italy, United Kingdom
M.D. Anderson Cancer Center
Astellas Scientific & Medical Affairs, Inc.

Active, not recruiting

Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking

Ischemia

United States
Shire

Completed

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention-deficit/Hyperactivity Disorder

Spain, Belgium, United States, Netherlands, United Kingdom, Italy, Germany, Canada, France, Sweden
University of Illinois at Chicago
Astellas Pharma Inc

Completed

Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements

Coronary Artery Disease

United States
Samsung Medical Center

Completed

Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.

Overactive Bladder

Korea, Republic of
Jack Rubinstein
Forest Laboratories

Terminated

An Advanced Echocardiographic Evaluation of Nebivolol

Hypertension

United States
Kathy Miller

Terminated

Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis

Bone Cancer | Metastasis

United States
Bausch & Lomb Incorporated
ORA, Inc.

Completed

Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.

Hyperemia

United States
The University of Texas Health Science Center at...
Shire

Completed

Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity

United States
Mylan Bertek Pharmaceuticals

Completed

Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension

Hypertension

United States

Search clinical trials for: LHRH agonist

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations